Closing Indices

17 MAY 2022 

Bse Sensex Closed @ 54318.47 🔼 1344.63 Points 

Nse Nifty Closed @ 16259.30 🔼 417.00 Points 

Bank Nifty Closed @ 34301.90 🔼 704.30 Points 

India VIX Closed @ 22.7425 🔽 1.7850 Points

F&O Ban Stocks For 17.05.2022

Stock under F&O ban on NSE 17-May-22

1 GNFC 

2 IBULHSGFIN 

3 PNB

Corporate Updates

Today's Corporate Action 17th May Ex Date

MINDSPACE Income Distribution RITES

Today's Key Results/Board Meetings 17-May-22

ABBOTINDIA Audited Results;Dividend
ACRYSIL Quarterly Results;Final Dividend
AML General
ANUP Final Dividend;Audited Results
APMIN Audited Results;Dividend
ASCENSIVE Audited Results
ASHIKACR General;Audited Results;Dividend
AUTOAXLES Final Dividend;Audited Results
BAJAJELEC Audited Results;Dividend
BAJAJHCARE Quarterly Results;Final Dividend;Audited Results
BENGALS Audited Results
BHARTIARTL Audited Results;Dividend
BJDUP Audited Results
BRPL Quarterly Results;Audited Results
CFEL Final Dividend;Audited Results
CHITRTX General;Audited Results
CIL Audited Results
CITYONLINE General
CLIOINFO General;Audited Results
DANUBE Audited Results
DLF Audited Results;Dividend
DOLFIN General
DUNCANENG Audited Results
EASUN Audited Results
EIDPARRY Audited Results
EKI Increase in Authorised Capital;General;Bonus issue;Audited Results
ESARIND Increase in Authorised Capital;General;Issue Of Warrants
FAIRCHEMOR Final Dividend;Audited Results
GALAXYSURF Quarterly Results;Final Dividend;Audited Results
GMRINFRA Quarterly Results;Audited Results
GTLINFRA Audited Results
INDOCO Final Dividend;Audited Results
IOC Final Dividend;Bonus issue;Audited Results
IRB Audited Results
IVP General;Audited Results;Dividend
JETMALL Audited Results
JHACC Audited Results
JUBLINGREA Final Dividend;Audited Results
JYOTIRES General;Bonus issue;Audited Results;Dividend
KACHCHH Audited Results
KAJARIACER Final Dividend;Audited Results
KARTKIN Audited Results
KIRLFER Final Dividend;Audited Results
LACTOSE A.G.M.;General;Audited Results
LALPATHLAB Final Dividend;Audited Results
MANGCHEFER Audited Results;Dividend
MEDINOV Audited Results
MERMETL Quarterly Results;General;Audited Results
MINDACORP Final Dividend;Audited Results
MOTILALOFS Buy Back of Shares
MPILCORPL Quarterly Results
MPSLTD Final Dividend;Audited Results
MUKANDENGG Audited Results
MUKANDLTD Audited Results;Dividend
MUKATPIP Audited Results
MUKTAARTS Audited Results
MUTHTFN Audited Results
NOCIL Audited Results
NUCLEUS Final Dividend;Audited Results
ORIENTBELL Quarterly Results;Audited Results;Dividend
PIIND Final Dividend;Audited Results
PITHP Quarterly Results
PRAGBOS General;Audited Results
PREVEST Half Yearly Results;Audited Results
RAJSREESUG Audited Results
SANJIVIN Audited Results
SAPPHIRE Audited Results
SBC Audited Results
SCFL Quarterly Results;Audited Results
SHARONBIO Audited Results
SPARC Audited Results
STARCEMENT Quarterly Results;Audited Results
SUUMAYA General
TEJASSVI Audited Results
TEJNAKSH Audited Results
UDAICEMENT General;Audited Results
ULTRACAB Quarterly Results;Audited Results
VERITAS General
VIKSHEN Quarterly Results;Audited Results
ZYDUSWELL Final Dividend;Audited Results

Results on May 17

Today Results

Bharti Airtel, Indian Oil Corporation, DLF, PI Industries, Abbott India, Bajaj Electricals, Bajaj Healthcare, EID Parry (India), Indoco Remedies, IRB Infrastructure Developers, Jubilant Ingrevia, Kajaria Ceramics, Dr Lal PathLabs, Minda Corporation, Sapphire Foods India, Fairchem Organics, Galaxy Surfactants, GMR Infrastructure, NOCIL, Nucleus Software Exports, Sun Pharma Advanced Research Company, and Zydus Wellness will be in focus ahead of March quarter earnings on May 17.

In News

Stocks in News

Shares of PSU stocks will be under focus ahead of the Life Insurance Corporation of India's listing on May 17. The grey market premium trading at discount of Rs 30 a share. LIC likely to list at flat to negative on exchanges amid volatility in the global equity markets, analysts said. 

Shares of InterGlobe Aviation will be in focus after the firm said it got DGCA communications on handling of special child at Ranchi Airport. DGCA prima facie found Indigo's handling of special child at Ranchi Airport inappropriate. DGCA will issue a show cause notice to Indigo to explain. The firm said it will respond the matter in due course. 

Aditya Birla Capital said on exchanges that the firm has received whistleblower complaint where allegations were made against Aditya Birla Sun Life and employees. The firm said an independent committee investigating the complaint did not find any merit in any allegations. The firm also said that the complaint did not level allegations against CEO Ajay Srinivasan. Srinivasan had express interest in taking on a new role within the group leading to him to stepping down as CEO of Aditya Birla Capital. The firm also said that there have been no employee exit in Aditya Birla Capital and Aditya Birla Sun Life AMC due to the allegations. 

IRB Infrastructure on exchanges said its April gross toll collections stood at Rs 327 crore versus Rs 306.66 crore in March. The gross toll collections in April last year was at Rs 196.64 crore. The firm said on April 21 the toll collection was suspended on account of farmers agitation. 

KEC International won orders worth Rs 1,150 crore across its various businesses. The company said the diverse orders in the Civil business, further strengthen its portfolio diversification and reaffirms the company's confidence in the continued strong growth of this business going forward. 

State-owned SJVN Ltd will develop another hydro power project Arun-4 worth Rs 4,900 crore in Nepal. A Memorandum of Understanding (MoU) for the development of the 490 MW Arun-4 hydro electric project in Nepal has been signed in Lumbini, Nepal in the presence of Prime Minister Narendra Modi and Prime Minister of Nepal Sher Bahadur Deuba, the company said in a statement. 

GlaxoSmithKline Pharmaceuticals on Monday reported a Rs 55 crore consolidated net loss from continuing operations for the fourth quarter. The drug firm had reported a net profit of Rs 4 crore for the January-March quarter of the 2020-21 fiscal. Revenue from operations rose to Rs 810 crore for the fourth quarter compared to Rs 744 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing. 

VIP Industries said it reported a profit of Rs 12 crore in the March quarter from a loss of Rs 4 crore a year ago. Revenue for the quarter stood at Rs 356 crore versus Rs 243 crore last year. EBITDA was at Rs 33 crore against Rs 3 crore.